0000895345-13-000032.txt : 20130205 0000895345-13-000032.hdr.sgml : 20130205 20130205170831 ACCESSION NUMBER: 0000895345-13-000032 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130205 DATE AS OF CHANGE: 20130205 GROUP MEMBERS: MORTON HOLDINGS INC. GROUP MEMBERS: PHILIP B. KORSANT SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-34455 FILM NUMBER: 13574880 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SAMANA CAPITAL, L.P. CENTRAL INDEX KEY: 0001054458 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 153 EAST 53RD STREET 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2122925900 MAIL ADDRESS: STREET 1: 153 EAST 53RD STREET STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: ZIFF ASSET MANAGEMENT LP DATE OF NAME CHANGE: 19980204 SC 13G/A 1 ja13ga2-savient_samana.htm ja13ga2-savient_samana.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

 
SCHEDULE 13G
(Amendment No. 2)
 
 
Under the Securities Exchange Act of 1934
Savient Pharmaceuticals, Inc.
(Name of Issuer)
 
Common Stock, $.01 Par Value Per Share
(Title of Class of Securities)
 
80517Q100
(CUSIP Number)
 

December 31, 2012
(Date of Event which Requires Filing of this Statement)
 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
   o Rule 13d-1(b)
   x Rule 13d-1(c)
   o Rule 13d-1(d)
 
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 
 
 

CUSIP No. 80517Q100
13G
Page 2 of 9 Pages

 
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
          Samana Capital, L.P.
 
2
 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
 
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
          Delaware
 
NUMBER OF
SHARES
5
SOLE VOTING POWER
 
0
 
BENEFICIALLY
OWNED BY
6
SHARED VOTING POWER
 
                0
 
EACH
REPORTING
7
SOLE DISPOSITIVE POWER
 
0
 
PERSON
WITH
8
SHARED DISPOSITIVE POWER
 
                0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
0
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)             o
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
0%
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
PN
 
 
 
 
 
 
 

CUSIP No. 80517Q100
13G
Page 3 of 9 Pages

1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
          Morton Holdings, Inc.
 
2
 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
 
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
          Delaware
 
NUMBER OF
SHARES
5
SOLE VOTING POWER
 
0
 
BENEFICIALLY
OWNED BY
6
SHARED VOTING POWER
 
                0
 
EACH
REPORTING
7
SOLE DISPOSITIVE POWER
 
0
 
PERSON
WITH
8
SHARED DISPOSITIVE POWER
 
                0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
0
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
0%
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
CO
 
 
 
 
 
 
 
 
 
 

CUSIP No. 80517Q100
13G
Page 4 of 9 Pages

1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
          Philip B. Korsant
 
2
 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
 
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
          United States of America
 
NUMBER OF
SHARES
5
SOLE VOTING POWER
 
0
 
BENEFICIALLY
OWNED BY
6
SHARED VOTING POWER
 
                0
 
EACH
REPORTING
7
SOLE DISPOSITIVE POWER
 
0
 
PERSON
WITH
8
SHARED DISPOSITIVE POWER
 
                0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
0
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)        o
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
0%
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
IN
 
 
 
 
 
 
Item 1. (a)            Name of Issuer

Savient Pharmaceuticals, Inc.

Item 1. (b)            Address of Issuer’s Principal Executive Offices

One Tower Center, 14th Floor
East Brunswick, New Jersey 08816

Item 2. (a)           Name of Person Filing

This Schedule 13G is being filed on behalf of the following persons (the “Reporting Persons”)*:

(i)           Samana Capital, L.P. (“SC”);
(ii)          Morton Holdings, Inc. (“MH”); and
(iii)         Philip B. Korsant.

*           Attached as Exhibit A is a copy of an agreement among the Reporting Persons that this Schedule 13G is being filed on behalf of each of them.

Item 2. (b)           Address of Principal Business Office or, if None, Residence

Samana Capital, L.P.
35 Ocean Reef Drive
Suite 142
Key Largo, Florida 33037

Morton Holdings, Inc.
35 Ocean Reef Drive
Suite 142
Key Largo, Florida 33037

Philip B. Korsant
35 Ocean Reef Drive
Suite 142
Key Largo, Florida 33037

Item 2. (c)           Citizenship

See Item 4 of the attached cover pages.

Item 2. (d)           Title of Class of Securities

Common Stock, $.01 Par Value Per Share (the “Common Stock”)

Item 2. (e)           CUSIP Number

80517Q100

Item 3.

Not applicable as this Schedule 13G is filed pursuant to Rule 13d-1(c).

Item 4.                Ownership

Item 4 is hereby amended and restated in its entirety as follows:

(a)           Amount beneficially owned:

See Item 9 of the attached cover pages.

(b)           Percent of class:

See Item 11 of the attached cover pages.

(c)           Number of shares as to which such person has:
 
 
(i)
 
Sole power to vote or to direct the vote:
 
   
See Item 5 of the attached cover pages.
 
 
(ii)
 
Shared power to vote or to direct the vote:
 
   
See Item 6 of the attached cover pages.
 
 
(iii)
 
Sole power to dispose or to direct the disposition:
 
   
See Item 7 of the attached cover pages.
 
 
(iv)
 
 Shared power to dispose or to direct the disposition:
 
   
See Item 8 of the attached cover pages.
 
 
SC is the owner of record of the Common Stock reported herein.  MH is the general partner of SC.  Each of MH and Philip B. Korsant may be deemed to beneficially own the Common Stock reported herein as a result of the direct or indirect power to vote or dispose of such stock.

Item 5.                Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X].

Item 6.                Ownership of More than Five Percent on Behalf of Another Person

Not Applicable.

Item 7.                 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

Not Applicable.

Item 8.                 Identification and Classification of Members of the Group

Not Applicable.

Item 9.                 Notice of Dissolution of Group

Not Applicable.

Item 10.               Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 

 
SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:  February 5, 2013

 
SAMANA CAPITAL, L.P.
By:   Morton Holdings, Inc., its general partner
 
 
 
By:
/s/ David Gray
 
Name:
David Gray
 
Title:
Vice President

 
MORTON HOLDINGS, INC.
 
 
 
 
By:
/s/ David Gray
 
Name:
David Gray
 
Title:
Vice President
 
 
 
  /s/ Philip B. Korsant
  Philip B. Korsant


 
 
 



EXHIBIT A


The undersigned, Samana Capital, L.P., a Delaware limited partnership, Morton Holdings, Inc., a Delaware corporation, and Philip B. Korsant, hereby agree and acknowledge that the information required by this Schedule 13G, to which this Agreement is attached as an exhibit, is filed on behalf of each of them.  The undersigned further agree that any further amendments or supplements thereto shall also be filed on behalf of each of them.
 
Dated:  February 5, 2013

 
SAMANA CAPITAL, L.P.
By:           Morton Holdings, Inc., its general partner
 
 
 
By:
/s/ David Gray
 
Name:
David Gray
 
Title:
Vice President

 
MORTON HOLDINGS, INC.
 
 
 
 
By:
/s/ David Gray
 
Name:
David Gray
 
Title:
Vice President
 
 
 
  /s/ Philip B. Korsant
  Philip B. Korsant